PT Indofarma Persero Tbk announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was IDR 749,255.138 million compared to IDR 583,537.509 million a year ago. Operating income was IDR 6,933.274 million compared to operating loss of IDR 12,871.050 million a year ago. Net loss was IDR 18,881.523 million compared to IDR 34,842.248 million a year ago. Basic loss per share was IDR 6.09 compared to IDR 11.24 a year ago.